The Beauty Health Company

NasdaqCM:SKIN Stock Report

Market Cap: US$132.3m

Beauty Health Management

Management criteria checks 1/4

Beauty Health's CEO is Marla Beck, appointed in Nov 2023, has a tenure of 1.5 years. total yearly compensation is $7.69M, comprised of 18.6% salary and 81.4% bonuses, including company stock and options. directly owns 0.29% of the company’s shares, worth $380.70K. The average tenure of the management team and the board of directors is 1.5 years and 4 years respectively.

Key information

Marla Beck

Chief executive officer

US$7.7m

Total compensation

CEO salary percentage18.6%
CEO tenure1.5yrs
CEO ownership0.3%
Management average tenure1.5yrs
Board average tenure4yrs

Recent management updates

Recent updates

The Beauty Health Company (NASDAQ:SKIN) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Apr 11
The Beauty Health Company (NASDAQ:SKIN) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny
author-image

Sales Execution And Hydralock Booster Launch Will Strengthen Future Prospects

Apr 02 Operational improvements and strategic market positioning are set to enhance profitability and boost revenue growth.

The Beauty Health Company (NASDAQ:SKIN) Analysts Just Cut Their EPS Forecasts Substantially

Mar 14
The Beauty Health Company (NASDAQ:SKIN) Analysts Just Cut Their EPS Forecasts Substantially

Is Beauty Health (NASDAQ:SKIN) Weighed On By Its Debt Load?

Feb 27
Is Beauty Health (NASDAQ:SKIN) Weighed On By Its Debt Load?

The Beauty Health Company (NASDAQ:SKIN) Doing What It Can To Lift Shares

Dec 27
The Beauty Health Company (NASDAQ:SKIN) Doing What It Can To Lift Shares

Health Check: How Prudently Does Beauty Health (NASDAQ:SKIN) Use Debt?

Oct 18
Health Check: How Prudently Does Beauty Health (NASDAQ:SKIN) Use Debt?

Positive Sentiment Still Eludes The Beauty Health Company (NASDAQ:SKIN) Following 33% Share Price Slump

Aug 06
Positive Sentiment Still Eludes The Beauty Health Company (NASDAQ:SKIN) Following 33% Share Price Slump

Is There Now An Opportunity In The Beauty Health Company (NASDAQ:SKIN)?

Jul 16
Is There Now An Opportunity In The Beauty Health Company (NASDAQ:SKIN)?

Not Many Are Piling Into The Beauty Health Company (NASDAQ:SKIN) Stock Yet As It Plummets 28%

Jun 14
Not Many Are Piling Into The Beauty Health Company (NASDAQ:SKIN) Stock Yet As It Plummets 28%

Calculating The Fair Value Of The Beauty Health Company (NASDAQ:SKIN)

May 30
Calculating The Fair Value Of The Beauty Health Company (NASDAQ:SKIN)

The Beauty Health Company (NASDAQ:SKIN) Stock Rockets 31% But Many Are Still Ignoring The Company

Feb 16
The Beauty Health Company (NASDAQ:SKIN) Stock Rockets 31% But Many Are Still Ignoring The Company

The Beauty Health Company's (NASDAQ:SKIN) Share Price Matching Investor Opinion

Jun 19
The Beauty Health Company's (NASDAQ:SKIN) Share Price Matching Investor Opinion

Is The Beauty Health Company (NASDAQ:SKIN) Trading At A 39% Discount?

May 28
Is The Beauty Health Company (NASDAQ:SKIN) Trading At A 39% Discount?

At US$13.26, Is The Beauty Health Company (NASDAQ:SKIN) Worth Looking At Closely?

Apr 04
At US$13.26, Is The Beauty Health Company (NASDAQ:SKIN) Worth Looking At Closely?

Beauty Health's (NASDAQ:SKIN) Earnings Are Of Questionable Quality

Mar 08
Beauty Health's (NASDAQ:SKIN) Earnings Are Of Questionable Quality

What Is The Beauty Health Company's (NASDAQ:SKIN) Share Price Doing?

Jan 01
What Is The Beauty Health Company's (NASDAQ:SKIN) Share Price Doing?

An Intrinsic Calculation For The Beauty Health Company (NASDAQ:SKIN) Suggests It's 24% Undervalued

Dec 05
An Intrinsic Calculation For The Beauty Health Company (NASDAQ:SKIN) Suggests It's 24% Undervalued

The Beauty Health Company: A Compelling Mid To Long-Term Growth Story

Oct 12

CEO Compensation Analysis

How has Marla Beck's remuneration changed compared to Beauty Health's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2024US$8mUS$1m

-US$29m

Sep 30 2024n/an/a

-US$28m

Jun 30 2024n/an/a

-US$84m

Mar 31 2024n/an/a

-US$81m

Dec 31 2023US$2mUS$185k

-US$100m

Sep 30 2023n/an/a

-US$84m

Jun 30 2023n/an/a

-US$10m

Mar 31 2023n/an/a

-US$7m

Dec 31 2022US$175kn/a

US$44m

Compensation vs Market: Marla's total compensation ($USD7.69M) is above average for companies of similar size in the US market ($USD682.63K).

Compensation vs Earnings: Marla's compensation has increased whilst the company is unprofitable.


CEO

Marla Beck (54 yo)

1.5yrs

Tenure

US$7,692,267

Compensation

Ms. Marla Malcolm Beck serves as Member of Board of Advisors of Glowbar, Inc. since January 2023. She is Director at GLO Pharma, Inc. since September 7, 2022. She was an Independent Director of The Beauty...


Leadership Team

NamePositionTenureCompensationOwnership
Marla Beck
President1.5yrsUS$7.69m0.29%
$ 380.7k
Michael Monahan
Chief Financial Officer1.8yrsUS$2.36m0.18%
$ 236.4k
Sheri Lewis
Chief Supply Chain & Operations Officer1.1yrsno data0.056%
$ 74.5k
Paul Bokota
Senior VP & General Counsel4.5yrsno datano data
Carrie Caulkins
Chief Marketing Officerless than a yearno datano data
Celeste Ortiz
Chief Human Resources Officer2.3yrsno datano data
Ronald Menezes
Chief Revenue Officer & Executive Officerless than a yearno datano data

1.5yrs

Average Tenure

56yo

Average Age

Experienced Management: SKIN's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Marla Beck
President2.9yrsUS$7.69m0.29%
$ 380.7k
Brian Miller
Independent Director4yrsUS$207.50k0.073%
$ 96.0k
Michael Capellas
Independent Director4yrsUS$215.00k0.16%
$ 207.5k
Stephen Fanning
Independent Directorless than a yearUS$820.000.36%
$ 476.9k
Douglas Schillinger
Independent Director4yrsUS$220.00k0.051%
$ 67.7k
Brenton Saunders
Chairman4yrsUS$295.00k6.82%
$ 9.0m
Desiree Gruber
Independent Director3.9yrsUS$202.50k0.033%
$ 43.0k
Michelle Kerrick
Independent Director4yrsUS$220.00k0.030%
$ 40.1k

4.0yrs

Average Tenure

58.5yo

Average Age

Experienced Board: SKIN's board of directors are considered experienced (4 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/07 09:14
End of Day Share Price 2025/05/07 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

The Beauty Health Company is covered by 13 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bruce JacksonBenchmark Company
Navann Ty DietschiBNP Paribas Exane
Kyle RoseCanaccord Genuity